BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38644243)

  • 41. Organ Preservation in Rectal Cancer After Chemoradiation: Should We Extend the Observation Period in Patients with a Clinical Near-Complete Response?
    Hupkens BJP; Maas M; Martens MH; van der Sande ME; Lambregts DMJ; Breukink SO; Melenhorst J; Houwers JB; Hoff C; Sosef MN; Leijtens JWA; Berbee M; Beets-Tan RGH; Beets GL
    Ann Surg Oncol; 2018 Jan; 25(1):197-203. PubMed ID: 29134378
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oncological and Survival Outcomes in Watch and Wait Patients With a Clinical Complete Response After Neoadjuvant Chemoradiotherapy for Rectal Cancer: A Systematic Review and Pooled Analysis.
    Dattani M; Heald RJ; Goussous G; Broadhurst J; São Julião GP; Habr-Gama A; Perez RO; Moran BJ
    Ann Surg; 2018 Dec; 268(6):955-967. PubMed ID: 29746338
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Early results from implementation of a 'watch and wait' protocol for complete clinical response following chemoradiotherapy for rectal cancer.
    Balasuriya HD; Timon C; Entriken F; Neely D; Herron J; Tang C; Van Hazel G; Warner MW
    ANZ J Surg; 2022 Nov; 92(11):2961-2967. PubMed ID: 35841184
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Risk of Distant Metastases in Patients With Clinical Complete Response Managed by Watch and Wait After Neoadjuvant Therapy for Rectal Cancer: The Influence of Local Regrowth in the International Watch and Wait Database.
    Fernandez LM; São Julião GP; Renehan AG; Beets GL; Papoila AL; Vailati BB; Bahadoer RR; Kranenbarg EM; Roodvoets AGH; Figueiredo NL; Van De Velde CJH; Habr-Gama A; Perez RO;
    Dis Colon Rectum; 2023 Jan; 66(1):41-49. PubMed ID: 36515514
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Dynamic Clinical Calculator for Estimating Conditional Recurrence-Free Survival After Total Neoadjuvant Therapy for Rectal Cancer and Either Surgery or Watch-and-Wait Management.
    Weiser MR; Chou JF; Kim JK; Widmar M; Wei IH; Pappou EP; Smith JJ; Nash GM; Paty PB; Cercek A; Saltz LB; Romesser PB; Crane CH; Garcia-Aguilar J; Schrag D; Gönen M
    JAMA Netw Open; 2022 Sep; 5(9):e2233859. PubMed ID: 36173634
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rectal cancer with complete clinical response after neoadjuvant chemoradiotherapy, surgery, or "watch and wait".
    Lai CL; Lai MJ; Wu CC; Jao SW; Hsiao CW
    Int J Colorectal Dis; 2016 Feb; 31(2):413-9. PubMed ID: 26607907
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Observation of "complete clinical response" in rectal cancer after neoadjuvant chemoradiation: The Flinders experience.
    Sposato LA; Lam Y; Karapetis C; Vatandoust S; Roy A; Hakendorf P; Dwyer A; de Fontgalland D; Hollington P; Wattchow D
    Asia Pac J Clin Oncol; 2018 Dec; 14(6):439-445. PubMed ID: 29932278
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Chinese expert consensus on the watch and wait strategy in rectal cancer patients after neoadjuvant treatment (2024 version)].
    ; ; ; ;
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):301-315. PubMed ID: 38644235
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and safety of wait and see strategy versus radical surgery and local excision for rectal cancer with cCR response after neoadjuvant chemoradiotherapy: a meta-analysis.
    Zhao GH; Deng L; Ye DM; Wang WH; Yan Y; Yu T
    World J Surg Oncol; 2020 Aug; 18(1):232. PubMed ID: 32862826
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term Oncological and Functional Outcomes of Chemoradiotherapy Followed by Organ-Sparing Transanal Endoscopic Microsurgery for Distal Rectal Cancer: The CARTS Study.
    Stijns RCH; de Graaf EJR; Punt CJA; Nagtegaal ID; Nuyttens JJME; van Meerten E; Tanis PJ; de Hingh IHJT; van der Schelling GP; Acherman Y; Leijtens JWA; Bremers AJA; Beets GL; Hoff C; Verhoef C; Marijnen CAM; de Wilt JHW;
    JAMA Surg; 2019 Jan; 154(1):47-54. PubMed ID: 30304338
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Conditional Survival in Patients With Rectal Cancer and Complete Clinical Response Managed by Watch and Wait After Chemoradiation: Recurrence Risk Over Time.
    São Julião GP; Karagkounis G; Fernandez LM; Habr-Gama A; Vailati BB; Dattani M; Kalady MF; Perez RO
    Ann Surg; 2020 Jul; 272(1):138-144. PubMed ID: 30946085
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Outcome and Salvage Surgery Following "Watch and Wait" for Rectal Cancer after Neoadjuvant Therapy: A Systematic Review.
    Kong JC; Guerra GR; Warrier SK; Ramsay RG; Heriot AG
    Dis Colon Rectum; 2017 Mar; 60(3):335-345. PubMed ID: 28177997
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and safety of the "watch-and-wait" approach for rectal cancer with clinical complete response after neoadjuvant chemoradiotherapy: a meta-analysis.
    Zhang X; Ding R; Li J; Wu T; Shen Z; Li S; Zhang Y; Dong C; Shang Z; Zhou H; Li T; Li G; Li Y
    Surg Endosc; 2022 Apr; 36(4):2233-2244. PubMed ID: 34981233
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term outcomes of transanal endoscopic microsurgery for clinical complete response after neoadjuvant treatment in T2-3 rectal cancer.
    González JEB; Lavernia HC; Fraga JGP; Lemus SQ
    Surg Endosc; 2022 May; 36(5):2906-2913. PubMed ID: 34231071
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Application of imaging diagnosis in watch and wait strategy for locally advanced rectal cancer patients after neoadjuvant therapy].
    Zhang XY; Lu QY; Sun YS
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):243-247. PubMed ID: 32192302
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Rational evaluation of the complete response after neoadjuvant therapy in locally advanced mid-low rectal cancer: the pros and cons of "watch and wait" strategy].
    Gu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):507-513. PubMed ID: 31238630
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Thoughts on the watch and wait strategy of patients with rectal cancer after neoadjuvant therapy].
    Wen RB; Zhang W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):230-236. PubMed ID: 32192300
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nonoperative management after neoadjuvant therapy for rectal cancer: A single institution experience over 5 years.
    Strode M; Shah R; Boland PM; Francescutti VA; Mangieri CW; Attwood K; Nurkin SJ
    Surg Oncol; 2019 Mar; 28():116-120. PubMed ID: 30851884
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Patient-Reported Bowel Function in Patients With Rectal Cancer Managed by a Watch-and-Wait Strategy After Neoadjuvant Therapy: A Case-Control Study.
    Quezada-Diaz FF; Smith JJ; Jimenez-Rodriguez RM; Wasserman I; Pappou EP; Patil S; Wei IH; Nash GM; Guillem JG; Weiser MR; Paty PB; Garcia-Aguilar J
    Dis Colon Rectum; 2020 Jul; 63(7):897-902. PubMed ID: 32217857
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Consensus on the Watch and Wait policy in rectal cancer patients after neoadjuvant treatment (2020 version)].
    ; ; ; ;
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jan; 23(1):1-9. PubMed ID: 31958923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.